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We read with much interest the article by Nolan et al. (1)
on insulin resistance (IR) as a defense against metabolic
stress. This is the third in a cluster of reviews beginning
with the hypothesis that IR protects the heart from fuel
overload in dysregulated metabolic states (2) and coin-
cides with a review by Connor et al. (3). In our article
(2), we stressed the deleterious effects of dysregulated
glucose and fat metabolism on the function of the heart
and proposed physiologic and biochemical mechanisms by
which IR protects the heart from fuel overload. Nolan
et al. (1) focused on insulin-induced metabolic stress and
expanded on the view that overriding IR with intensive
insulin treatment could be harmful (4). Lastly, Connor et
al. (3) stressed that many of the adaptations occurring in
metabolic diseases characterized by nutritional excess can
be viewed as protective in nature rather than pathogenic
per se. The observations that excessive insulin signaling
exacerbates systolic dysfunction when the heart is sub-
jected to pressure overload (5) and the demonstration
that IR improves metabolic and contractile efﬁciency in
the inotropically challenged heart (6) complement each
other. Lowering blood glucose levels at all costs may be
harmful. We have proposed that in the management of
diabetes of patients with heart failure the target should be
the source rather than the destination of excess fuel (7).
The three reviews and other published work (8) argue in
support of the concept that IR is a physiological defense
mechanism against metabolic stress. One can only hope
that the concept will gain further traction.
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